At a glance
ClinicalIndex Comparison RecordN/ACompleted· 125 enrolled
Drug / intervention
Intensive adherence instruction +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Study About the Impact of Intensive Instruction on the Use of Aricept and the Reasons for Discontinuation in Patients With Alzheimer's Disease
In Brief
A clinical study evaluating Intensive adherence instruction and Control for Alzheimer's Type Dementia. Completed, enrolled 125 participants across 1 site.
Detailed Summary
The purpose of this study is to examine the influence of the instruction on the use of Aricept with educational brochure on the 48-week medication persistence and to assess the reasons for discontinuation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlzheimer's Type Dementia
CountriesJapan
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartSep 2013
First PostedOct 2013
Primary CompletionAug 2017
TodayJul 2026
First PostedOct 30, 2013
Enrollment StartSep 1, 2013
Primary CompletionAug 1, 2017
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 12.7 years ago
Interventions
Intensive adherence instructionbehavioral
Instruction with educational brochure
Controlbehavioral
Instruction as per usual practice